抗生素相关的脑病变诱导的塞夫在血液透析患者:病例报告
Toshiyuki Nakanishi1, Taku Harada2, Satoshi Kutsuna1
1Department of Infectious Disease, The University of Osaka Hospital, Osaka, Japan.
概括
甲 (CMZ) 是一种β-乳糖抗生素,可以引起抗生素相关脑病变 (AAE),这是一个罕见的神经复杂症. 这一案例突显了CMZ诱导的功能障碍患者的AAE,强调了早期识别.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 腎臟病學 (nephrology) 是一種醫學.
背景情况:
- 抗生素相关脑病变 (AAE) 是已知的β-乳糖抗生素的并发症,特别是在功能障碍患者中.
- 虽然有几种β-乳酸盐是已知的原因,但 cefmetazole (CMZ) 神经毒性较少被记录.
- 末期病 (ESRD) 患者特别容易受到药物诱导的神经系统不良事件的影响.
研究的目的:
- 报告一种由塞夫马他诱导的抗生素相关脑病变的病例.
- 为了突出CEFmetazole在患有功能障碍的患者中的潜在神经毒性.
- 强调在这种患者群体中对改变精神状态的差异诊断中考虑AAE的重要性.
主要方法:
- 一个82岁的男性患有ESRD在血液透析上的病例报告.
- 静脉注射塞夫马他 (CMZ) 用于治疗前列腺.
- 改变精神状态的临床表现和肌细胞结核.
- 诊断工作包括EEG,神经成像和CSF分析.
- 使用Naranjo药物不良反应概率尺度进行评估.
主要成果:
- 患者在开始静脉注射CMZ5天后出现精神状态变化和肌肉化.
- 脑电图显示了三相波,表明非状态.
- 神经成像和脑脊液分析排除了感染和中风.
- 症状在停止使用CMZ后48小时内消失.
- 纳拉尼奥分数为5表示可能是CMZ引起的AAE.
结论:
- 塞夫梅他 (CMZ) 可以引起与抗生素相关的脑病变 (AAE),即使没有得到广泛认可.
- 患有功能障碍的患者,特别是接受血液透析的患者,患CMZ神经毒性风险增加.
- 早期识别和停止违规抗生素对管理CMZ诱导的AAE至关重要.
相关概念视频
01:20Antiepileptic Drugs: Potassium Channel Activators
611
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
611
01:24Hemodialysis II: Procedure and Complications
573
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
573
01:25Hemodialysis I: Introduction
1.2K
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
1.2K
01:25Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
486
Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
486
01:26Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
164
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
164
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
167
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
167